176 related articles for article (PubMed ID: 1830034)
21. [Transfection of thymidine phosphorylase cDNA with lentiviral vector enhances the anticancer effect of 5'-deoxy-5-fluorouridine on colorectal cancer cell lines HT29 and LS174T].
Ye D; Wang Q; Zhang J; Liu Q
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):18-24. PubMed ID: 25877313
[TBL] [Abstract][Full Text] [Related]
22. In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin.
Iigo M; Nishikata K; Hoshi A
Jpn J Cancer Res; 1992 Apr; 83(4):392-6. PubMed ID: 1387127
[TBL] [Abstract][Full Text] [Related]
23. Irreversible cytotoxic effect of a novel lowly immunosuppressive antitumor fluorouridine derivative, UK-21.
Mori H; Nakayama K; Ishida R; Ito S; Nagai H; Koda A
Anticancer Drugs; 1997 Jun; 8(5):482-8. PubMed ID: 9215612
[TBL] [Abstract][Full Text] [Related]
24. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.
Hillman GG; Puri RK; Kukuruga MA; Pontes JE; Haas GP
Clin Exp Immunol; 1994 Jun; 96(3):476-83. PubMed ID: 8004818
[TBL] [Abstract][Full Text] [Related]
25. Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro.
Correale P; Aquino A; Giuliani A; Pellegrini M; Micheli L; Cusi MG; Nencini C; Petrioli R; Prete SP; De Vecchis L; Turriziani M; Giorgi G; Bonmassar E; Francini G
Int J Cancer; 2003 Apr; 104(4):437-45. PubMed ID: 12584740
[TBL] [Abstract][Full Text] [Related]
26. HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.
Beniers AJ; Peelen WP; Debruyne FM; Schalken JA
Int J Cancer; 1991 Jul; 48(5):709-16. PubMed ID: 1906431
[TBL] [Abstract][Full Text] [Related]
27. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon.
Ziai MR; Imberti L; Tongson A; Ferrone S
Cancer Res; 1985 Nov; 45(11 Pt 2):5877-82. PubMed ID: 3931909
[TBL] [Abstract][Full Text] [Related]
28. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.
Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J
Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040
[TBL] [Abstract][Full Text] [Related]
29. The difference in mechanism of action of 5-fluorouracil and its nucleosides in L5178y cells.
Yoshida M; Hoshi A; Kuretani K
J Pharmacobiodyn; 1980 Aug; 3(8):374-9. PubMed ID: 6451683
[TBL] [Abstract][Full Text] [Related]
30. Cytolytic activity of interferon-gamma and its synergism with 5-fluorouracil.
Le J; Yip YK; Vilcek J
Int J Cancer; 1984 Oct; 34(4):495-500. PubMed ID: 6436183
[TBL] [Abstract][Full Text] [Related]
31. Concentration and time dependence of the toxicity of fluorinated pyrimidines to HT 29 colorectal carcinoma cells.
Link KH; Aigner KR; Peschau K; Warthona M; Schwemmle K; Danenberg PV
Cancer Chemother Pharmacol; 1988; 22(1):58-62. PubMed ID: 2969305
[TBL] [Abstract][Full Text] [Related]
32. Antiproliferative effects exerted by recombinant human tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) on human pancreatic tumor cell lines.
Schmiegel WH; Caesar J; Kalthoff H; Greten H; Schreiber HW; Thiele HG
Pancreas; 1988; 3(2):180-8. PubMed ID: 3131759
[TBL] [Abstract][Full Text] [Related]
33. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.
Chu E; Koeller DM; Johnston PG; Zinn S; Allegra CJ
Mol Pharmacol; 1993 Apr; 43(4):527-33. PubMed ID: 8474431
[TBL] [Abstract][Full Text] [Related]
34. Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites.
Elias L; Crissman HA
Cancer Res; 1988 Sep; 48(17):4868-73. PubMed ID: 2457431
[TBL] [Abstract][Full Text] [Related]
35. Direct IFNluence of interferon-gamma on proliferation and cell-surface antigen expression of non-small cell lung cancer cells.
Yano T; Sugio K; Yamazaki K; Kase S; Yamaguchi M; Ondo K; Sugimachi K
Lung Cancer; 2000 Dec; 30(3):169-74. PubMed ID: 11137201
[TBL] [Abstract][Full Text] [Related]
36. Carcinoembryonic antigen expression level as a predictive factor for response to 5-fluorouracil in colorectal cancer.
Eftekhar E; Naghibalhossaini F
Mol Biol Rep; 2014 Jan; 41(1):459-66. PubMed ID: 24293105
[TBL] [Abstract][Full Text] [Related]
37. Modulation of human leukocyte antigen class I expression by gamma interferon in head and neck cancer cell lines.
Houck JR; Shah TP; Ohlsson-Wilhelm BM; Kloszewski E; Conner BR
Am J Otolaryngol; 1988; 9(5):217-23. PubMed ID: 3147605
[TBL] [Abstract][Full Text] [Related]
38. Antiproliferative effects of cytokines on squamous cell carcinoma.
Sacchi M; Klapan I; Johnson JT; Whiteside TL
Arch Otolaryngol Head Neck Surg; 1991 Mar; 117(3):321-6. PubMed ID: 1900161
[TBL] [Abstract][Full Text] [Related]
39. Rate-limiting steps in the interactions of fluoropyrimidines and methotrexate.
Bowen D; Bailey BD; Guernsey LA
Eur J Cancer Clin Oncol; 1984 May; 20(5):651-7. PubMed ID: 6234172
[TBL] [Abstract][Full Text] [Related]
40. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
Maio M; Gulwani B; Morgano A; Ferrone S
Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
